UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators

Journal of thoracic oncology, 2014-05, Vol.9 (5), p.631-638

2014

Link zum Volltext

Verfügbarkeit prüfen

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1248-1268

2018

Link zum Volltext

Verfügbarkeit prüfen

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Journal of thoracic oncology, 2016-07, Vol.11 (7), p.946-963

2016

Link zum Volltext

Verfügbarkeit prüfen

Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer

Journal of thoracic oncology, 2012-02, Vol.7 (2), p.340-347

2012

Link zum Volltext

Verfügbarkeit prüfen

The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

Journal of thoracic oncology, 2012-06, Vol.7 (6), p.947-953

2012

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1302-1311

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic

Journal of thoracic oncology, 2020-07, Vol.15 (7), p.1119-1136

2020

Link zum Volltext

Verfügbarkeit prüfen

Fluorescence In Situ Hybridization, Immunohistochemistry, and Next‐Generation Sequencing for Detection of EML4‐ALK Rearrangement in Lung Cancer

The oncologist (Dayton, Ohio), 2015-03, Vol.20 (3), p.316-322

2015

Link zum Volltext

Verfügbarkeit prüfen

FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies

Clinical cancer research, 2014-06, Vol.20 (12), p.3299-3309

2014

Link zum Volltext

Verfügbarkeit prüfen

The tissue is the issue: personalized medicine for non-small cell lung cancer

Clinical cancer research, 2010-10, Vol.16 (20), p.4909-4911

2010

Link zum Volltext

Verfügbarkeit prüfen

Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer

Journal of thoracic oncology, 2011-01, Vol.6 (1), p.21-27

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations

Journal of thoracic oncology, 2010-10, Vol.5 (10), p.1551-1558

2010

Link zum Volltext

Verfügbarkeit prüfen

Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2012-09, Vol.7 (9), p.e14-e16

2012

Link zum Volltext

Verfügbarkeit prüfen

Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis

American journal of respiratory and critical care medicine, 2018-10, Vol.198 (7), p.914-927

2018

Link zum Volltext

Verfügbarkeit prüfen

The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

Journal of thoracic oncology, 2020-09, Vol.15 (9), p.1434-1448

2020

Link zum Volltext

Verfügbarkeit prüfen

Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression

Journal of thoracic oncology, 2013-12, Vol.8 (12), p.1492-1501

2013

Link zum Volltext

Verfügbarkeit prüfen

Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed

Journal of thoracic oncology, 2013-01, Vol.8 (1), p.19-30

2013

Link zum Volltext

Verfügbarkeit prüfen

Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis

The Journal of immunology (1950), 2011-07, Vol.187 (1), p.527-537

2011

Link zum Volltext

Verfügbarkeit prüfen

EGFR Protein Expression in Non-Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor―A Novel Antibody for Immunohistochemistry or AQUA Technology

Clinical cancer research, 2011-12, Vol.17 (24), p.7796-7807

2011

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer

Cellular oncology (Dordrecht), 2013-07, Vol.36 (4), p.277-288

2013

Link zum Volltext

Verfügbarkeit prüfen

Independent validation test of the vote-counting strategy used to rank biomarkers from published studies

Biomarkers in medicine, 2015-08, Vol.9 (8), p.751-761

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(77)
Dissertationen
(1)

Sprache

Englisch
(78)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(52)
Humans
(43)
Oncology
(36)
Respiratory System
(34)
Female
(18)
Lung Neoplasms - Genetics
(18)
Lung Neoplasms - Pathology
(17)
Male
(17)
Middle Aged
(16)
Lung Neoplasms - Drug Therapy
(14)
Aged
(13)
Animals
(13)
Carcinoma, Non-Small-Cell Lung - Genetics
(12)
Lung Cancer
(12)
Mice
(11)
Pulmonary And Respiratory Medicine
(11)
Lung Neoplasms - Metabolism
(10)
Neoplasm Staging
(10)
Prognosis
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer

The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic

Fluorescence In Situ Hybridization, Immunohistochemistry, and Next‐Generation Sequencing for Detection of EML4‐ALK Rearrangement in Lung Cancer

FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies

The tissue is the issue: personalized medicine for non-small cell lung cancer

Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations

Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer

Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis

The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative

The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression

Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed

Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis

EGFR Protein Expression in Non-Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor―A Novel Antibody for Immunohistochemistry or AQUA Technology

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer

Independent validation test of the vote-counting strategy used to rank biomarkers from published studies

Suchergebnisse filtern